Andrew A. Radin & Andrew M. Radin
The 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.
Looking for 8-10 startups to present their tech on April 12 at the 2022 MIT Health Science Technologies Conference: The Future of Cell & Gene Therapies.
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
MIT Startup Exchange will select 4 startups to present and exhibit at the 2025 MIT Health & Science Forum on May 8.
Amgen launches 2023 LabCentral Golden Ticket competition for innovative life science startups, awarding two startups with with lab space, amenities, and services.
The Bristol Myers Squibb 2021 Golden Ticket Contest is a competition for the award of two Golden Tickets, which covers the cost of one 6-ft lab bench and one resident scientist fee for one year for a promising life science start-up.